Daniel Hasler
Oprichter bij Hasler Ventures LLC
Oorsprong van het eerstegraads netwerk van Daniel Hasler
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
ReElement Technologies LLC
ReElement Technologies LLC Other Metals/MineralsNon-Energy Minerals Part of American Resources Corp. (Indiana), ReElement Technologies LLC is a company that focuses on redefining how critical and rare earth elements are sourced and processed. The company is based in Fishers, IN. The company has developed its innovative and scalable "capture-process-purify" process chain in conjunction with its licensed intellectual property including 16 patents and technologies and sponsored research partnerships with three leading universities to support the domestic supply chains growing demand for magnet and battery metals. ReElement Technologies is committed to recycling end-of-life products such as rare earth permanent magnets and lithium-ion batteries, as well as coal-based waste streams and byproducts to create a low-cost and environmentally-safe, circular supply chain. The CEO of the company is Mark C. Jensen.
5
| Subsidiary | Other Metals/Minerals | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Daniel Hasler via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
MAGNA INTERNATIONAL INC. | Auto Parts: OEM | President | |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Trading-Equity | |
SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
T Squared Partners LLC
T Squared Partners LLC Investment ManagersFinance T Squared Partners LLC operates as a private investment firm. It provides expansion, working, acquisition, and restructuring capital. The firm focuses on providing strategic insight to its portfolio companies to help them navigate the process of going public, acquisitions, and raising additional capital via debt and equity. The company was founded by Mark C. Jensen and Thomas M. Sauve and is headquartered in New York, NY. | Investment Managers | Founder Founder | |
T Squared Capital LLC
T Squared Capital LLC Investment ManagersFinance T Squared Investments LLC (T Squared Capital) is a private equity firm founded in 2007 by Thomas M. Sauve and Mark C. Jensen. The firm is headquartered in New York. | Investment Managers | Founder Founder | |
University of Virginia | College/University | Undergraduate Degree | |
Boston University | College/University | Undergraduate Degree | |
University of Salford | College/University | Graduate Degree | |
Ball State University (Indiana) | College/University | Graduate Degree | |
Boron Molecular Ltd.
Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Boron Molecular Ltd. manufactures fine chemicals. Its products include biaryls, boronic acid esters and acids, catalyst, cubanes, diborons, energy storage, halides, polymer, raft agents, and trifluoroborates. The company was founded in 2001 and is headquartered in Noble Park, Australia. | Chemicals: Major Diversified | Chief Executive Officer | |
Amperex Technology Ltd.
Amperex Technology Ltd. Electrical ProductsProducer Manufacturing Amperex Technology Ltd. designs, manufactures and sells lithium ion polymer battery cells and related battery packs and systems. Its lithium battery products uses in consumer electronics products like laptop computers, smart and cellular phone, digital media players, digital cameras and camcorders, cordless tools and in IT gadgets. The firm’s products are also used in electrical vehicles and electrical energy storage markets. The company was founded in October 1999 by Raymond Leung and is headquartered in Hong Kong. | Electrical Products | President | |
SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Warwick | College/University | Doctorate Degree | |
The University of Western Australia | College/University | Doctorate Degree | |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of New England (Australia) | College/University | Masters Business Admin | |
FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
University of California | College/University | Masters Business Admin | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
On Target Laboratories LLC
On Target Laboratories LLC BiotechnologyHealth Technology On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL. | Biotechnology | Director/Board Member Founder | |
Kelley School of Business | College/University | Undergraduate Degree | |
CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
University of Rochester Simon Business School | College/University | Undergraduate Degree | |
National Alliance For Advanced Technology Batteries | Chief Tech/Sci/R&D Officer | ||
QUINCE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Anzu Partners LLC
Anzu Partners LLC Investment ManagersFinance Anzu Partners LLC (Anzu Partners) is a venture capital firm founded in 2014 by David Michael and David Seldin. The firm is headquartered in Washington, District of Columbia. | Investment Managers | Consultant / Advisor | |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member | |
Applaud Medical, Inc.
Applaud Medical, Inc. Medical SpecialtiesHealth Technology Applaud Medical, Inc. engages in the development of medical devices for kidney stone treatment. The company was founded by Thomas William Kenny, Jr. and Claire Mills in 2014 and is headquartered in San Francisco, CA. | Medical Specialties | Director/Board Member | |
AMERICAN RESOURCES CORPORATION | Coal | Chief Executive Officer Public Communications Contact President | |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Biotechnology | Director/Board Member Founder | |
Land Betterment Corp.
Land Betterment Corp. Miscellaneous Commercial ServicesCommercial Services Land Betterment Corp. is a private company based in Fishers, IN and has subsidiaries in the United States. Land Betterment Corp. was founded in 2020 by Kirk P. Taylor and Mark C. Jensen. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Novusterra, Inc.
Novusterra, Inc. Other Metals/MineralsNon-Energy Minerals Novusterra, Inc. is an emerging growth company. It engages in the business of rare earth element processing facility to process & refine rare earth material. The company was founded on September 21, 2020 and is headquartered in Miami, FL. | Other Metals/Minerals | Chairman Chairman | |
GRAPHENE MANUFACTURING GROUP LTD | Electrical Products | Director/Board Member | |
CATL (CONTEMPORARY AMPEREX TECHNOLOGY) | Electrical Products | Chief Tech/Sci/R&D Officer | |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 33 |
Australië | 5 |
Canada | 3 |
Verenigd Koninkrijk | 3 |
Israël | 2 |
Sectoraal
Health Technology | 15 |
Consumer Services | 11 |
Finance | 10 |
Producer Manufacturing | 5 |
Commercial Services | 4 |
Operationeel
Director/Board Member | 75 |
Corporate Officer/Principal | 34 |
Founder | 17 |
Chairman | 15 |
Independent Dir/Board Member | 13 |
Sterkste connecties
Insiders | |
---|---|
Franklyn Prendergast | 43 |
Karen Smith | 29 |
William J. Rutter | 22 |
Mark Jensen | 15 |
Thomas Sauve | 12 |
Philip Low | 10 |
Bob Galyen | 10 |
Mark J. LaVerghetta | 8 |
Alex Andrianopoulos | 7 |
Brendan Hannah | 5 |
Stewart A. Low | 1 |
Jeff Peterson | 1 |
- Beurs
- Insiders
- Daniel Hasler
- Bedrijfsconnecties